Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tonix Pharmaceuticals Holding (TNXP) Inventory: 2023-2025

Historic Inventory for Tonix Pharmaceuticals Holding (TNXP) over the last 3 years, with Sep 2025 value amounting to $5.7 million.

  • Tonix Pharmaceuticals Holding's Inventory fell 27.76% to $5.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $5.7 million, marking a year-over-year decrease of 27.76%. This contributed to the annual value of $8.4 million for FY2024, which is 38.35% down from last year.
  • Tonix Pharmaceuticals Holding's Inventory amounted to $5.7 million in Q3 2025, which was down 4.29% from $6.0 million recorded in Q2 2025.
  • Tonix Pharmaceuticals Holding's 5-year Inventory high stood at $13.7 million for Q2 2023, and its period low was $5.7 million during Q3 2025.
  • Moreover, its 3-year median value for Inventory was $8.9 million (2024), whereas its average is $9.9 million.
  • Data for Tonix Pharmaceuticals Holding's Inventory shows a maximum YoY tumbled of 40.54% (in 2024) over the last 5 years.
  • Quarterly analysis of 3 years shows Tonix Pharmaceuticals Holding's Inventory stood at $13.6 million in 2023, then crashed by 38.35% to $8.4 million in 2024, then fell by 27.76% to $5.7 million in 2025.
  • Its Inventory was $5.7 million in Q3 2025, compared to $6.0 million in Q2 2025 and $8.1 million in Q1 2025.